Neuronetics (STIM) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.11% |
| Dec 31, 2025 | 54.79% |
| Sep 30, 2025 | -22.33% |
| Jun 30, 2025 | 25.62% |
| Mar 31, 2025 | 12.64% |
| Dec 31, 2024 | -9.65% |
| Sep 30, 2024 | -9.21% |
| Jun 30, 2024 | 16.82% |
| Mar 31, 2024 | -17.71% |
| Dec 31, 2023 | -12.35% |
| Sep 30, 2023 | -8.76% |
| Jun 30, 2023 | 12.63% |
| Mar 31, 2023 | -14.58% |
| Dec 31, 2022 | -2.98% |
| Sep 30, 2022 | -1.13% |
| Jun 30, 2022 | -2.18% |
| Mar 31, 2022 | 32.24% |
| Dec 31, 2021 | -13.16% |
| Sep 30, 2021 | -2.39% |
| Jun 30, 2021 | -8.52% |
| Mar 31, 2021 | 44.85% |
| Dec 31, 2020 | 44.93% |
| Sep 30, 2020 | 61.92% |
| Jun 30, 2020 | -45.99% |
| Mar 31, 2020 | 22.54% |
| Dec 31, 2019 | 4.50% |
| Sep 30, 2019 | -8.61% |
| Jun 30, 2019 | 103.99% |
| Mar 31, 2019 | 32.19% |
| Dec 31, 2018 | -63.13% |
| Sep 30, 2018 | 435.42% |
| Jun 30, 2018 | 33.33% |
| Mar 31, 2018 | -28.36% |
| Dec 31, 2017 | 107.22% |
| Sep 30, 2017 | -37.82% |